This activity is accredited for Immunizations credit.
Program Description
Hepatitis B is a vaccine-preventable liver infection caused by the hepatitis B virus (HBV). In the United States and globally, HBV infections continue to be a serious health issue, and the latest statistics indicate that more than 290 million individuals worldwide are infected with the virus. The implementation of effective vaccination programs has resulted in a significant decrease in the incidence of new hepatitis B infections; however, HBV infection remains a leading cause of morbidity and mortality in many regions of the globe. As vaccination leaders, pharmacists need to be familiar with complications associated with HBV infections and recommend HBV vaccination for specific patient populations. This activity will review the significance of HBV vaccination and types of HBV vaccines available, with a focus on recent advancements in hepatitis B vaccines. Strategies for pharmacists to address barriers to HBV vaccination and improve vaccination rates to align with ACIP recommendations will be explored.
Target audience: Retail pharmacists
Type of activity: Application
Release date: August 12, 2022
Expiration date: March 1, 2024
Time to complete activity: 2.0 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Examine the incidence, etiology and complications associated with hepatitis B virus (HBV) infections including risk factors and the burden of untreated infections
- Explore current standards of care and novel vaccines for prevention of HBV infection, including dosage, administration, and safety
- Explain the updated 2021 ACIP recommendations for HBV vaccination in adults
- Identify the role of the pharmacist in expanding rates of HBV vaccination in the adult patient population
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
